HealthCor Catalio Acquisition Corp. (HCAQ)
|52 Week Range||10.06-10.93|
|1y Target Est||-|
|DCF Unlevered||HCAQ DCF ->|
|DCF Levered||HCAQ LDCF ->|
|Debt / Equity||-111.42%||Sell|
Upgrades & Downgrades
Latest HCAQ news
Portable MRI Device Maker Hyerfine Going Public Via SPAC: What Investors Should Know
8 July 2021
An MRI scanner on wheels is the highlight of Hyperfine, a company that announced a SPAC merger Thursday morning. The SPAC Deal: Hyperfine Inc and Liminal Sciences are merging with HelathCor Catalio Ac...
Hyperfine, Inc., Creator of the First FDA-Cleared Portable MRI Device, and Liminal Sciences, Inc. To...
8 July 2021
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. and Liminal Sciences, Inc. to be listed on Nasdaq through a business combination with HealthCor Catalio Acquisition Corp.
HealthCor Catalio Acquisition Corp. Announces Closing of Upsized $207 Million Initial Public Offerin...
29 January 2021
NEW YORK, Jan. 29, 2021 /PRNewswire/ -- HealthCor Catalio Acquisition Corp. (the "Company"), a special purpose acquisition company formed for the purpose of entering into a combination with one or mor...
HealthCor Catalio Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in New York, New York.
Stock Value >
Financial Summary > Financial Statements > Financial Quarter Statements > Ratios Analysis > Dupont Analysis > Free Cash Flow > Operating Data > Balance Sheet Data >